CareFusion announces plans to acquire GE Healhcare's Vital Signs division for $500 million

CareFusion announced on November 18, 2013 that it would acquire GE Healthcare's Vital Signs division in a $500 million deal. The acquisition will double CareFusion's Specialty Disposables business to over $500 million in annual revenues and establishes the company as a leader in Vital Signs' focu...

This item has been archived in line with our efforts to keep our content relevant and up to date for our readership. For further assistance, please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!

Related Research

NERv Technology's latest investment round will support the company in its next steps toward clinical trials but with limits

News Commentary | May 07, 2021

NERv Technology, a Canadian medical sensor startup, raised a $2.65 million seed round investment that it plans to use toward seeking regulatory approval, completing clinical trials, and establishing production lines. The company's sensor technology focuses on monitoring postoperative complications, ... Not part of subscription

Pear Therapeutics acquires DTx assets used to treat depression, in sign of a warming market for tech-aided therapy

News Commentary | December 22, 2021

The acquisition of Waypoint Health Innovations further underscores Pear’s focus on its psychiatry portfolio. Before this acquisition, Pear already had a product in its development pipeline (Pear‑015). Waypoint's assets deliver cognitive behavioral therapy that dynamically personalizes each ... To read more, click here.

News Trends: Digital health Q1 2022 update

Analyst Insight | April 21, 2022

The first quarter of 2022 saw a number of interesting developments across the many different verticals of digital health. Partnerships, acquisitions, funding, and product developments over a variety of markets have grown since the end of 2021. Partnerships across the world of digital therapeutics... Not part of subscription